((自动化翻译由路透提供，请见免责声明 ))
11月26日 - ** 安进公司 股价盘前下跌7.1%至279.01美元
** 该公司的实验性药物MariTide导致平均体重减轻20% (link)，该公司周二表示，一些分析师认为这一结果是投资者的最低标准。
** William Blair & Co公司分析师马特-菲普斯（Matt Phipps）在数据公布前曾表示，许多投资者希望体重减轻接近25%。
** 11月12日，AMGN股价暴跌约7%，因为Cantor Fitzgerald的分析师称，他们对该药物早期数据的审查显示，骨矿密度下降 (link)，这会增加骨折风险。
** AMGN的股价今年以来上涨了2%。
<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Amgen stock performance
^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.